H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 131 Citations 95,634 492 World Ranking 988 National Ranking 17

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Endocrinology

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Albuminuria, Diabetic nephropathy and Diabetes mellitus. His Internal medicine research is multidisciplinary, relying on both Type 1 diabetes and Nephropathy. While the research belongs to areas of Endocrinology, he spends his time largely on the problem of Urology, intersecting his research to questions surrounding Angiotensin II and Irbesartan.

His Albuminuria study combines topics in areas such as Creatinine, Microalbuminuria, Type 2 diabetes and Captopril. His study in Diabetic nephropathy is interdisciplinary in nature, drawing from both Odds ratio and Incidence. His biological study spans a wide range of topics, including Gastroenterology, Surgery, Immunopathology and Risk factor.

His most cited work include:

  • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. (2704 citations)
  • Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes (2650 citations)
  • Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy (955 citations)

What are the main themes of his work throughout his whole career to date?

Hans-Henrik Parving mainly focuses on Internal medicine, Endocrinology, Diabetes mellitus, Diabetic nephropathy and Albuminuria. His Internal medicine study typically links adjacent topics like Nephropathy. As part of the same scientific family, Hans-Henrik Parving usually focuses on Endocrinology, concentrating on Cardiology and intersecting with Left ventricular hypertrophy.

The study incorporates disciplines such as Gastroenterology, Surgery and Risk factor in addition to Diabetes mellitus. In Diabetic nephropathy, Hans-Henrik Parving works on issues like Angiotensin-converting enzyme, which are connected to Angiotensin II receptor type 1. His Albuminuria study combines topics from a wide range of disciplines, such as Excretion and Hazard ratio.

He most often published in these fields:

  • Internal medicine (85.11%)
  • Endocrinology (67.31%)
  • Diabetes mellitus (57.61%)

What were the highlights of his more recent work (between 2006-2021)?

  • Internal medicine (85.11%)
  • Endocrinology (67.31%)
  • Diabetes mellitus (57.61%)

In recent papers he was focusing on the following fields of study:

Hans-Henrik Parving mainly investigates Internal medicine, Endocrinology, Diabetes mellitus, Albuminuria and Diabetic nephropathy. His studies deal with areas such as Type 1 diabetes and Type 2 diabetes as well as Internal medicine. In the field of Endocrinology, his study on Nephropathy, Blood pressure, Vitamin D and neurology and Angiotensin II overlaps with subjects such as Crossover study.

The Diabetes mellitus study which covers Gastroenterology that intersects with Proportional hazards model. Hans-Henrik Parving focuses mostly in the field of Albuminuria, narrowing it down to matters related to Urology and, in some cases, Aliskiren and Losartan. His Diabetic nephropathy study frequently links to related topics such as Pathogenesis.

Between 2006 and 2021, his most popular works were:

  • Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes (2650 citations)
  • Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy (955 citations)
  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts (482 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Endocrinology

His scientific interests lie mostly in Internal medicine, Albuminuria, Endocrinology, Renal function and Diabetes mellitus. His work deals with themes such as Type 1 diabetes and Type 2 diabetes, which intersect with Internal medicine. His work in Albuminuria tackles topics such as Microalbuminuria which are related to areas like Proteinuria, Prospective cohort study and Uric acid.

Endocrinology is often connected to Urology in his work. His study focuses on the intersection of Diabetes mellitus and fields such as Gastroenterology with connections in the field of vitamin D deficiency, Vitamin D and neurology, Endothelium, Endothelial dysfunction and Excretion. His Kidney disease study deals with Nephropathy intersecting with Ambulatory blood pressure, Observational study and Follow up studies.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Hans-Henrik Parving;Hendrik Lehnert;Jens Bröchner-Mortensen;Ramon Gomis.
The New England Journal of Medicine (2001)

4247 Citations

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

Peter Gæde;Henrik Lund-Andersen;Hans-Henrik Parving;Oluf Pedersen.
The New England Journal of Medicine (2008)

3984 Citations

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

Hans-Henrik Parving;Frederik Persson;Julia B. Lewis;Edmund J. Lewis.
The New England Journal of Medicine (2008)

1493 Citations

Nephropathy in diabetes.

Mark E Molitch;Ralph A DeFronzo;Marion J Franz;William F Keane.
Diabetes Care (2004)

1306 Citations

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

Peter Gaede;Pernille Vedel;Hans Henrik Parving;Oluf Pedersen.
The Lancet (1999)

1254 Citations

EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY

Hans-Henrik Parving;UllaM Smidt;AllanR Andersen;PerAa Svendsen.
The Lancet (1983)

1235 Citations

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

Dick De Zeeuw;Giuseppe Remuzzi;Hans Henrik Parving;William F. Keane.
Kidney International (2004)

1100 Citations

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death

Coen D.A. Stehouwer;Mari-Anne Gall;Jos W.R. Twisk;Elisabeth Knudsen.
Diabetes (2002)

902 Citations

Prevention of diabetic renal disease with special reference to microalbuminuria

C. E. Mogensen;W. F. Keane;P. H. Bennett;G. E. Striker.
The Lancet (1995)

817 Citations

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

H H Parving;B Oxenbøll;P A Svendsen;J S Christiansen.
European Journal of Endocrinology (1982)

778 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Hans-Henrik Parving

Peter Rossing

Peter Rossing

Steno Diabetes Center

Publications: 339

Dick de Zeeuw

Dick de Zeeuw

University Medical Center Groningen

Publications: 180

Hiddo J.L. Heerspink

Hiddo J.L. Heerspink

George Institute for Global Health

Publications: 150

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 147

Mark E. Cooper

Mark E. Cooper

Monash University

Publications: 136

George L. Bakris

George L. Bakris

University of Chicago

Publications: 134

Allan Flyvbjerg

Allan Flyvbjerg

Steno Diabetes Center

Publications: 112

Per-Henrik Groop

Per-Henrik Groop

University of Helsinki

Publications: 109

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 108

Harald Mischak

Harald Mischak

University of Glasgow

Publications: 105

Coen D.A. Stehouwer

Coen D.A. Stehouwer

Maastricht University

Publications: 98

Ron T. Gansevoort

Ron T. Gansevoort

University Medical Center Groningen

Publications: 85

Lise Tarnow

Lise Tarnow

Steno Diabetes Center

Publications: 83

Andrzej S. Krolewski

Andrzej S. Krolewski

Joslin Diabetes Center

Publications: 79

Andrew S. Levey

Andrew S. Levey

Tufts Medical Center

Publications: 78

Something went wrong. Please try again later.